Biology Services
Navigating the Future of Medicine: Transforming Health Outcomes with Cutting-Edge Biologics Expertise.
Navigating the Future of Medicine: Transforming Health Outcomes with Cutting-Edge Biologics Expertise.
We are dedicated to advancing biologics through innovative solutions and expertise, guiding drug development from research to market launch, ensuring confidence in achieving therapeutic goals and navigating complexities.
We cater comprehensive services for biologic drug development, covering early-stage research to post-market surveillance, ensuring the success of biologic therapies through end-to-end solutions.
Biologic medications, derived from living creatures, offer innovative therapies for various diseases. Zenovel’s Biologic Services assists in developing and launching complex biologics, providing comprehensive support that meets regulatory requirements, marking a new frontier in medicine.
Our state-of-the-art laboratories and production facilities utilize the latest technology to deliver reliable and high- quality outcomes.
Provides a comprehensive and efficient biologic development pathway by seamlessly integrating services throughout the entire lifecycle.
Our team of scientists and regulatory experts is well-versed in biologic drug development, ensuring your projects benefit from the latest advancements and best practices.
Ensures the quality and regulatory compliance of its biologic products, ensuring they meet all necessary requirements and are safe for patient use.
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S Certification) is
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.